Terveystalo Plc: Terveystalo sells the entire share capital of Porin Linnankulma Mutual Real Estate Company

Terveystalo Plc Stock Exchange Release 16 April 2018 at 14.30 EET

Suomen Terveystalo Oy has entered into an agreement with the eQ Hoivakiinteistö Mutual Fund on 16 April 2018, with which Terveystalo sells the entire share capital of Porin Linnankulma Mutual Real Estate Company to eQ. The debt-free purchase price of the real estate company is approximately EUR 16 million and the net debt-adjusted purchase price of shares is approximately EUR 7 million. Terveystalo estimates that the transaction will generate a non-recurring capital gain of approximately EUR 6 million.

Terveystalo will continue to operate as a tenant in the premises on a fixed term ten-year contract.

“With this transaction, we are able to release capital for our business development. The arrangement contributes to improving the solvency of the Terveystalo Group and facilitating the implementation of our strategy,” says Terveystalo‘s CFO Ilkka Laurila.

Terveystalo Plc

For more information, please :
Kati Kaksonen, Director, Investor Relations and Financial Communications
Tel. +358 10 345 2034
Kati.kaksonen 

Distribution:
Nasdaq Helsinki Oy
Main media
www.terveystalo

Terveystalo in brief

Terveystalo is a listed company on the Helsinki Stock Exchange. Terveystalo is the largest healthcare service company in Finland with net sales and network. The company offers versatile primary and secondary health care services for corporate and private customers and the public sector. The nationwide network covers approximately 180 locations across Finland, complemented by 24/7 digital services.

In 2017, the Company had approximately 1.2 million individual customers and approximately 3.3 million doctor visits. Nearly 9,000 healthcare professionals work in Terveystalo, about half of whom are private practitioners. Terveystalo is a member of Association for Finnish Work. www.terveystalo

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.